Patents by Inventor Jens Kateb

Jens Kateb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11279682
    Abstract: The present invention provides vortioxetine pyroglutamate salt and pharmaceutical compositions comprising said salt.
    Type: Grant
    Filed: March 6, 2019
    Date of Patent: March 22, 2022
    Assignee: H. Lundbeck A/S
    Inventors: Heidi Lopez de Diego, Kim Lasse Christensen, Rene Holm, Jens Kateb
  • Publication number: 20210395208
    Abstract: The present invention relates to compositions comprising amorphous compounds of Formula (I) or amorphous compounds of Formula (I) salts and to processes for obtaining these. In particular, the invention relates to compositions comprising amorphous compounds of Formula (I) hydrogen fumarate and to processes for obtaining this. Further, the invention also relates to compositions comprising amorphous base of compounds of Formula (I) and to processes for obtaining this. The invention also relates to pharmaceutical compositions comprising amorphous compounds of Formula (I) or amorphous compounds of Formula (I) salts for treatment of psychiatric disorders such as schizophrenia, including Treatment Resistant Schizophrenia (TRS).
    Type: Application
    Filed: October 28, 2019
    Publication date: December 23, 2021
    Applicant: H. Lundeck A/S
    Inventors: Jens Kateb, Matthias Manne Knopp
  • Publication number: 20190210987
    Abstract: The present invention provides vortioxetine pyroglutamate salt and pharmaceutical compositions comprising said salt
    Type: Application
    Filed: March 6, 2019
    Publication date: July 11, 2019
    Inventors: Heidi Lopez de Diego, Kim Lasse Christensen, Rene Holm, Jens Kateb
  • Patent number: 10287261
    Abstract: The present invention provides vortioxetine pyroglutamate salt and pharmaceutical compositions comprising said salt.
    Type: Grant
    Filed: May 12, 2016
    Date of Patent: May 14, 2019
    Assignee: H. Lundbeck A/S
    Inventors: Heidi Lopez de Diego, Kim Lasse Christensen, Rene Holm, Jens Kateb
  • Publication number: 20160368884
    Abstract: The present invention provides vortioxetine pyroglutamate salt and pharmaceutical compositions comprising said salt.
    Type: Application
    Filed: May 12, 2016
    Publication date: December 22, 2016
    Inventors: Heidi Lopez de Diego, Kim Lasse Christensen, Rene Holm, Jens Kateb
  • Publication number: 20160256398
    Abstract: Pharmaceutical compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine and pharmaceutically acceptable acid addition salts thereof adapted so that release does not take place in the stomach is provided.
    Type: Application
    Filed: October 19, 2015
    Publication date: September 8, 2016
    Inventors: Astrid-Maria Hojer, Pernille Gundorf Drewes, Jens Kateb
  • Publication number: 20150150867
    Abstract: Pharmaceutical compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine and pharmaceutically acceptable acid addition salts thereof adapted so that release does not take place in the stomach is provided.
    Type: Application
    Filed: February 4, 2015
    Publication date: June 4, 2015
    Inventors: Astrid-Maria Hojer, Pernille Gundorf Drewes, Jens Kateb
  • Publication number: 20120189697
    Abstract: Pharmaceutical compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine and pharmaceutically acceptable acid addition salts thereof adapted so that release does not take place in the stomach is provided.
    Type: Application
    Filed: August 23, 2010
    Publication date: July 26, 2012
    Applicant: H. LUNDBECK A/S
    Inventors: Astrid-Maria Hojer, Pernille Gundorf Drewes, Jens Kateb